Month: October 2024

qtq80-YNdFQl

Approval in U.K. for new Alzheimer’s drug, but not approved for reimbursement in U.K. National Health Service

2024-10-23

On October 23, 2024, the U.K. Medicines and Healthcare products Regulatory Agency announced approval of...

qtq80-eVaCw1

UPDATE: FDA to reconsider tirzepatide shortage decision in response to litigation from Industry

2024-10-14

On October 7, 2024, the Outsourcing Facilities Association (OFA) filed litigation against FDA in the...

qtq80-eVaCw1

Shortage resolved for Eli Lilly’s GLP-1, tirzepatide-compounders reminded of restrictions

2024-10-03

FDA announced on October 2, 2024 that the shortage had been resolved for Eli Lilly's...